Cipla Limited

U & I Pharmaceuticals, Ltd.

Amar Lulla

Geena Malhotra

Xerxes Rao

Shrinivas Madhukar Purandare

Preeti Raut

A pharmaceutical composition for inhalation comprising R (+) budesonide and one or more bronchodilators, and, optionally, one or more pharmaceutically acceptable excipients is described.

Pharmaceutical compositions

A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.

Combination of azelastine and fluticasone for nasal administration

This invention relates to pharmaceutical products and compositions for use in the treatment of asthma and related disorders, and especially but not exclusively for the treatment of chronic obstructive pulmonary disease (COPD). More particularly, the invention provides pharmaceutical products and compositions comprising specific anticholinergic agents, &#x3b2;-2 agonists and corticosteroids.

Pharmaceutical products and composition comprising specific anticholinergic agents, &#x3b2;-2 agonists and corticosteroids

A pharmaceutical composition comprising a solid unit dosage form comprising:

Anti-retroviral combination

Combination of azelastine and mometasone for nasal administration

Combination of azelastine and ciclesonide for nasal administration

An inhaler () device for inhalation of a medicament from a pierceable capsule () comprises a housing () for receiving a medicament, capsule, closure means () for closing the housing, said closure means being moveable relative to the housing; piercing means () suitable for piercing a medicament capsule; wherein movement of the closure means relative to the housing causes movement of the piercing means, and wherein the device comprises an air inlet () and an air outlet () defining an inhalation passage therebetween, the passage comprising one or more vents ().

Dry powder inhaler

A valve for an aerosol device includes a valve assembly receivable in an opening provided in a container of the aerosol device to close the opening and includes a seal between the valve assembly and the container.

Valve for an aerosol device

A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.

Growing community of inventors

Mumbai, India

Amar Lulla